Adsorption therapy in critically ill with septic shock and acute kidney injury: a retrospective and prospective cohort study

作者
Gregor Alexander Schittek,Philipp Zoidl,Michael Eichinger,Simon Orlob,Holger Simonis,Martin Rief,Philipp Metnitz,Tobias Fellinger,Jens Soukup
出处
期刊:Annals of Intensive Care [Springer Nature]
卷期号:10 (1): 154-154 被引量:29
标识
DOI:10.1186/s13613-020-00772-7
摘要

Haemoadsorption has been described as an effective way to control increased pro- and anti-inflammatory mediators (“cytokine storm”) in septic shock patients. No prospective or randomised clinical study has yet confirmed these results. However, no study has yet prospectively specifically investigated patients in severe septic shock with sepsis-associated acute kidney injury (SA-AKI). Therefore, we aimed to examine whether haemoadsorption could influence intensive care unit (ICU) and hospital mortality in these patients. Furthermore, we examined the influence of haemoadsorption on length of stay in the ICU and therapeutic support. Retrospective control group and prospective intervention group design in a tertiary hospital in central Europe (Germany). Intervention was the implementation of haemoadsorption for patients in septic shock with SA-AKI. 76 patients were included in this analysis. Severity of illness as depicted by APACHE II was higher in patients treated with haemoadsorption. Risk-adjusted ICU mortality rates (O/E ratios) did not differ significantly between the groups (0.80 vs. 0.83). We observed in patients treated with haemoadsorption a shorter LOS and shorter therapeutic support such as catecholamine dependency and duration of RRT. However, in multivariate analysis (logistic regression for mortality, competing risk for LOS), we found no significant differences between the two groups. The implementation of haemoadsorption for patients in septic shock with acute renal failure did not lead to a reduction in ICU or hospital mortality rates. Despite univariate analysis delivering some evidence for a shorter duration of ICU-related treatments in the haemoadsorption group, these results did not remain significant in multivariate analysis. Trial registration CytoSorb® registry https://clinicaltrials.gov/ct2/show/NCT02312024 . December 9, 2014. Database: https://www.cytosorb-registry.org/ (registration for content acquisition is necessary)

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
穆里完成签到 ,获得积分10
1秒前
sci_zt完成签到 ,获得积分10
2秒前
怡然的岱周完成签到 ,获得积分10
2秒前
青云完成签到,获得积分10
4秒前
6秒前
Wolfe完成签到,获得积分10
7秒前
xiaoyu完成签到 ,获得积分10
8秒前
11完成签到 ,获得积分10
8秒前
饭二完成签到 ,获得积分10
11秒前
军旅醉了发布了新的文献求助10
12秒前
HelloBOB完成签到 ,获得积分10
12秒前
xue完成签到 ,获得积分10
12秒前
采采完成签到,获得积分10
14秒前
科研通AI6.2的应助被艾泽勒采纳,获得10
16秒前
科研通AI6.4的应助被艾泽勒采纳,获得10
16秒前
科研通AI6.4的应助被艾泽勒采纳,获得10
16秒前
bkagyin的应助被艾泽勒采纳,获得10
16秒前
科研通AI6.4的应助被艾泽勒采纳,获得10
16秒前
虚拟的岩完成签到 ,获得积分10
17秒前
自然心情完成签到 ,获得积分10
18秒前
loii的应助被小金刚采纳,获得30
20秒前
pp完成签到 ,获得积分10
20秒前
努力的学完成签到,获得积分10
21秒前
21秒前
啊元完成签到,获得积分10
22秒前
悟123完成签到 ,获得积分10
25秒前
风格完成签到,获得积分10
25秒前
昵称完成签到 ,获得积分10
28秒前
xn完成签到,获得积分10
28秒前
KYTYYDS完成签到,获得积分10
30秒前
大方念云完成签到 ,获得积分10
32秒前
yurunxintian完成签到,获得积分10
33秒前
小小布丁丁完成签到 ,获得积分10
38秒前
帅气羊完成签到 ,获得积分10
38秒前
cube完成签到 ,获得积分10
39秒前
Psychexin完成签到,获得积分10
39秒前
Eric发布了新的文献求助10
41秒前
Lucas的应助被刻苦的阁采纳,获得10
41秒前
23完成签到 ,获得积分10
41秒前
今后的应助被艾泽勒采纳,获得10
41秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Sustainable Engineered Micro/Nanofibers and Hybrid Nanocomposites for Environmental Remediation 400
Ecotourism 400
Liquidus diagram and viscosity estimation in pseudo-binary system Li2B6O10–LiF 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8076070
求助须知:如何正确求助?哪些是违规求助? 9494162
关于积分的说明 21378363
捐赠科研通 7644017
什么是DOI,文献DOI怎么找? 3399993
关于科研通互助平台的介绍 2529768
邀请新用户注册赠送积分活动 2438664